Phytomedicine is primarily a therapy-oriented Journal. Phytomedicine publishes innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts, phytopharmaceuticals and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations and purified compounds which have a defined and consistent quality assuring reproducible pharmacological activity. Phytomedicine was founded in 1994 to focus and stimulate research in this particular field and to set internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy and safety of phytomedicines. ?The main aims of Phytomedicine are associated with the integration of phytopreparations into conventional/official medicine. The journal covers the following sections:Clinical pharmacology and toxicology (randomized, placebo controlled, double blind, and observational open label studies)Behavioural, mental, affective, and stress-associated disordersAge-associated disordersNeuropharmacologyEndocrine pharmacologyMetabolic syndrome and obesityCancerImmunopharmacology, inflammationInfectious diseasesPulmonary, gastrointestinal, cardiovascular and urogenital diseasesSystems biologySafety assessment, pre-clinical toxicology, interaction with drugs and adverse events of herbal preparationsPharmacokinetic of natural compoundsStandardization of herbal preparationsLegislation of botanicalsInvited reviews

植物醫學主要是以治療為導向的期刊。植物醫學發表關于特定植物提取物、植物藥物及其分離成分的功效、安全性、質量和作用機制的創新研究。這包括臨床、藥理學、藥代動力學和對特定草藥產品、草藥制劑和純化化合物的毒理學研究，這些產品具有明確和一致的質量，保證了可重現的藥理活性。植物醫學成立于1994年，旨在關注和促進這一特定領域的研究，并為植物醫學的藥理研究、臨床療效證明和安全性制定國際公認的科學標準。植物醫學的主要目的是將植物修復納入常規/官方醫學。該雜志包括以下各部分:臨床藥理學和毒理學(隨機、安慰劑對照、雙盲和觀察性開放標簽研究)行為、心理、情感和壓力相關障礙與年齡有關的疾病神經藥理學內分泌藥理學代謝綜合癥與肥胖癌癥免疫藥理學、炎癥傳染病肺、胃腸、心血管和泌尿生殖系統疾病系統生物學安全性評估，臨床前毒理學，與藥物的相互作用和草藥制劑的不良事件天然化合物的藥動學中藥制劑標準化立法的植物邀請評審